Dr Madeleine Wilwerth

Quick facts

Phase 3 pipeline

• Levobupivacaine 0.07% + Sufentanil 0.3µg/ml · Anesthesia and Pain Management
  Levobupivacaine blocks sodium channels to provide local anesthesia, while sufentanil activates opioid receptors to provide analgesia, together delivering regional anesthesia and pain relief.
• Levobupivacaine 0.1% + Sufentanil 0.2µg/ml · Anesthesia / Pain Management
  Levobupivacaine blocks sodium channels to provide local anesthesia, while sufentanil activates opioid receptors to provide analgesia, together delivering regional anesthesia and pain relief.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Dr Madeleine Wilwerth portfolio CI brief
• Dr Madeleine Wilwerth pipeline updates RSS